Skip to main content
. 2020 Dec 22;11:598980. doi: 10.3389/fneur.2020.598980

Table 1.

Demographics and neuropsychological profile (participant and comparison groups).

Participant n = 1 A–/T– HCn = 99 A+/T+ MCI n = 16 A+/T+ ADn = 21
Age
Median (IQR)a 63 72.6 (70.4–75.4) 72.8 (69.0–76.4) 73.7 (66.0–77.6)
Sex
Male, n (%) Male 47 (47.5%) 11 (68.8%) 11 (52.4%)
MMSE
Median (IQR) 29 29 (28–30) 26 (23–28) 23 (17–25)
CDR
Mean (SD) 0.5 0.04 (0.13) 0.5 (0) 0.88 (0.44)
Years of education
Median (IQR) 15 15 (12–16) 11 (10–15) 11 (10–15)
Centiloid value
Median (IQR) 51 −0.6 (−3.5–3.6) 128 (100–148) 124 (96–141)
HADS-Db
Median (IQR) 7.0 1.0 (1.0–2.0) 2.0 (1.0–3.3) 2.5 (1.0–5.8)
HADS-Ac
Median (IQR) 6.0 3.0 (2.0–4.3) 5.0 (4.0–7.0) 4.0 (2.0–6.0)
Premorbid IQ
Median (IQR) 110 114 (109–117) 109 (102–111) 104 (101–112)
Neuropsychological measures (z-scores)
Word list recalld −2.27 1.13 (0.81) −1.75 (0.82) −2.18 (0.77)
RCFT copy score −0.54 -0.98 (1.09) −2.76 (2.83) −4.63 (6.52)
RCFT (3-min delayed recall) −2.31 1.14 (1.45) −1.70 (0.67) −2.22 (1.04)
RCFT (30-min delayed recall) −3.85 1.21 (1.56) −1.79 (0.69) −2.32 (1.19)
COWAT −0.66 0.97 (1.09) -0.19 (1.19) −0.20 (1.10)
Trail Making Task B −0.33
Digit span 0.33 0.64 (1.01) 0.19 (1.09) −0.44 (0.90)
Digit symbol coding 0.66 0.92 (0.82) −0.33 (0.79) −0.96 (0.99)

A–/T–, amyloid-β negative, tau negative; A+/T+, amyloid-β positive, tau positive; MMSE, Mini-Mental State Examination; CDR, Clinical Dementia Rating scale; HADS-D, Depression subscale of the Hospital Anxiety and Depression Scale; HADS-A, Anxiety subscale of the Hospital Anxiety and Depression Scale; RCFT, Rey Complex Figure Test; COWAT, Controlled Oral Word Association Test (component of the Delis-Kaplan Executive Function System verbal fluency test).

Mean (SD) for all neuropsychological z-scores.

a

The case participant was 63 years of age at the time of neuropsychological assessment, amyloid, and tau imaging.

b

HADS-D: raw score; 0–7 = low score (none–mild symptoms); 8–10 = moderate; 11–21 = high (21).

c

HADS-A: raw score; 0–7 = low score (none–mild symptoms); 8–10 = moderate; 11–21 = high (21).

d

Participant was administered the Rey Auditory Verbal Learning Test (RAVLT), while comparison groups were administered the California Verbal Learning Test (CVLT).